Latest Strategy News

NAOS Ex-50 Opportunities Company Limited reported a strong FY25 with a 28.92% portfolio return and maintained its annual dividend at 6.0 cents per share, reflecting robust capital management and investor confidence.

Codan Limited has delivered a robust FY25 performance, with revenue up 22% and net profit rising 27%, underpinned by strong growth in its Communications and Metal Detection segments. The company also announced a 27% increase in dividends and a significant reduction in net debt.

Eureka Group Holdings Limited reported robust FY25 financial results, driven by strong rental demand and strategic acquisitions across Queensland and New South Wales. The company signals continued growth with a significant development pipeline and optimistic FY26 guidance.

Downer EDI Limited has announced an on-market buy-back of up to 33.6 million ordinary shares, set to run from September 2025 through June 2026. The move signals a strategic capital management initiative without requiring shareholder approval.

Eureka Group Holdings reports robust FY25 results with double-digit revenue and profit growth, boosted by strong rental demand and strategic acquisitions. The company signals continued expansion and operational efficiency improvements ahead.

Universal Store Holdings reported a robust FY25 with 15.5% revenue growth to $333.3 million, driven by strong like-for-like sales and new store openings. Despite a goodwill impairment in its CTC segment, the group declared a solid final dividend and advanced its sustainability agenda.

Diablo Resources is progressing exploration at its Phoenix Copper Project in Utah, targeting copper mineralisation near the producing Lisbon Valley Mine. Assay results from ongoing drilling and sampling are expected soon, supported by streamlined US permitting.

Eureka Group Holdings Limited has reported a robust financial year ending June 2025, with net profit soaring 51.9% and a strategic portfolio expansion in seniors and affordable rental accommodation.

Sonic Healthcare Limited has announced an ordinary dividend of AUD 0.63 per share for the first half of 2025, with a 35% franking component and payment scheduled for mid-September.

Qube Holdings delivered a robust FY25 performance with underlying revenue up 27.3% and a 7.1% dividend increase, despite a significant impairment of its MITCo investment. The company’s diversified logistics and grain trading operations powered growth amid industrial and weather challenges.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.